B+
Bull case
20%
Probability
Target price
$1.90
+53.2% vs current
BON
Bon Natural LifeANasdaq / Materials
Last Price
At close
2026-06-03
AI scenario view
RankAlpha Sentiment AIMost likely
B
Base case
50%
Probability
Target price
$1.30
+4.8% vs current
B-
Bear case
30%
Probability
Target price
$0.70
-43.5% vs current
AI sentiment snapshot
Latest data as of 2026-04-16
Recent news sentiment (30D)
+20.2
Positive
Company
-
Unavailable
Macro
+20.2
Positive
Pulse
+23.2
Positive
Sentiment proxy
+47.0
Score
AI commentary
Market coverage and analyst targets are thin; visible consensus clustering around $1.28–$1.36 suggests limited priced upside absent company‑specific milestones [#SERP-3] [#SERP-7]. Recent primary materials (IR/PR) emphasize product launches and cooperation agreements but lack dated milestone disclosures, keeping sentiment cautious and event‑driven [#IR-undated] [#PR-undated].
RankAlpha Sentiment AI - 2026-04-16
Open full AI memoEvidence flagged
Coverage is limited for this name. This memo is usable, but confidence is lower and evidence depth is thinner than a standard report.
Impact
tentative
Confidence
-
AI events
2026-07-15eventIR/PR updates on product commercialization and contract milestonesHigh impact
Investor‑relations page and press releases indicate planned product launches and cooperation updates; a dated PR/IR update confirming shipment volumes, milestone receipts, or amended contract terms would be a near‑term event to watch [#IR-undated] [#PR-undated].
2027-04-16catalystCommercial rollout and revenue recognition from US$26M cooperation agreementHigh impact
Company disclosed a cooperation agreement (US$26M) tied to next‑gen tea pigment / digestive‑health product cooperation with Beijing Huahai Keyuan; successful commercial rollout / initial revenue recognition would materially de‑risk growth expectations [#IR-undated] [#PR-undated].
Recommendation
N/A
No formal recommendation provided.
As of 2026-04-16 • Updated nightlySource: Internal modelMethodology